Developer docs
API playgroundTry for free, no card

Search company profiles

Moolec Science

Full company profile

uuid00023ky

Namestring
Moolec Science
Legal namestring
Moolec Science SA
Company typeenum
Public
Founded yearint
2025
Descriptiontext

Moolec Science SA is a molecular farming company that produces animal proteins and specialty oils in genetically engineered crops, trading on NASDAQ under ticker MLEC following a June 2025 business combination with Bioceres Group, Gentle Technologies, and Nutrecon. The company's core technology is a plant-based expression platform that inserts target genes into safflower and pea seeds, producing functional ingredients at agricultural scale. Its lead commercial platform, GLASO1, yields gamma-linolenic acid (GLA)-rich safflower oil at approximately 45% concentration at commercial scale across 1,100 acres in the U.S., with 2025 campaign yields up 57% year-over-year. In April 2026, the company announced the first successful stable expression of bovine myoglobin in pea seeds via a 28-month sponsored research project with a U.S. academic institution, expanding the platform beyond oil crops into structured protein production.

Moolec generates revenue through direct B2B enterprise sales of GLA-rich safflower oil and specialty ingredients, initially targeting pet food manufacturers with planned expansion into human nutrition, dietary supplements, and specialty ingredient markets, and is also pursuing renewable energy feedstock applications through safflower. Following the 2025 merger, the portfolio was broadened to include the Mycofood™ fungal precision fermentation platform (acquired June 2025) and HB4® drought-tolerant soybeans through a supply agreement with Bioceres Crop Solutions. Pricing is not publicly disclosed. The company sells direct to enterprise customers leveraging existing U.S. agricultural and processing infrastructure.

Moolec is controlled by Union Group (founded by Uruguayan businessman Juan Sartori), employs 11-50 staff, and is headquartered in Warwick, UK, with a legal domicile in Uruguay and operations spanning the United States, Argentina, Australia, and Europe. The company has raised approximately $80 million since 2023, including a $50 million committed equity facility from Nomura (April 2023) and a $30 million convertible note financing led by Grupo Insud with Bioceres Crop Solutions (October 2023). It holds USDA-APHIS approval for its GLASO1 ingredient and SENASA feed/food approval in Argentina for safflower GLASO technology. The company regained Nasdaq minimum stockholders' equity compliance in May 2026 after a non-compliance notice in late 2025, and its market capitalization stood at approximately $5.28M as of April 2026 following a ~95.67% stock decline over the prior year.

Short descriptiontext

Moolec Science is a molecular farming company producing GLA-rich safflower oil and animal proteins (e.g., bovine myoglobin) in genetically engineered plants, serving B2B customers in pet food, human nutrition, and dietary supplements. It trades on NASDAQ as MLEC after its June 2025 merger with Bioceres Group.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLuxembourg, Luxembourg
HQ citystring
Luxembourg
HQ countrystring
Luxembourg
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
molecular farming proteins, alternative protein ingredients, specialty oil ingredients, plant-based proteins, precision fermentation ingredients
Industry5 codes
PRIMARYCRADAFAI
Alternative Protein & Sustainable Pet Food (insect/plant/cell-based)
SECONDARYAFAKAEAE
Specialty & Tropical Oils Processing (Avocado, Sesame, Peanut, Rice Bran, Grapeseed)
Agriculture & Food Production/Food Processing & Manufacturing/Edible Oils, Fats & Margarine Manufacturing
SECONDARYAFAKAGAG
Mycoprotein-Based Foods Manufacturing
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYEUAAAIAI
Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFADAKAF
Phytogenics & Botanicals (Essential Oils, Plant Extracts)
Agriculture & Food Production/Animal Feed Manufacturing/Medicated & Functional Feed (Coccidiostats, Probiotics, Performance Additives)
NAICS code4 codes
  • Fats and Oils Refining and Blending311225
  • Dog and Cat Food Manufacturing311111
  • Starch and Vegetable Fats and Oils Manufacturing31122
  • Other Animal Food Manufacturing311119
SIC code1 code
  • Fats & Oils2070
Product category
Alternative Protein Ingredients
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1GLA-Rich Safflower Oil Sales
TypeOne Time License
Description

Revenue from commercial-scale production and sale of GLA-enriched safflower oil to pet food, human nutrition, and dietary supplement markets.

stocktitan.net
2Specialty Ingredients
TypeTransaction Fee
Description

Revenue from high-concentration GLA softgel applications and specialty ingredient sales to nutrition and supplements market.

greenqueen.com.hk
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1GLASO1
Description

GLA-enriched safflower platform producing gamma-linolenic acid oil at commercial scale

markets.financialcontent.com
+1 more record
Core offering1 text field

Moolec Science develops and produces animal proteins and specialty oils using molecular farming technology—genetically engineering crops such as safflower and peas to express high-value proteins (e.g., bovine myoglobin) or fatty acids (e.g., gamma-linolenic acid/GLA). Its commercial flagship is the GLASO1 safflower platform producing GLA-rich safflower oil at commercial scale for pet food, human nutrition, and dietary supplement applications. The company also operates the Mycofood™ fungal precision fermentation platform acquired through its 2025 merger.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 45% GLA concentration at commercial scale from 1,100 acres, 57% yield increase year-over-year
+2 more records
Product overview1 text field

Moolec Science is a molecular farming company that develops animal proteins in plants across the US, Europe, and South America. The company operates primarily through its GLASO1 Safflower Platform, which produces GLA-rich safflower oil at commercial scale, and its Molecular Farming Platform, which expresses proteins like bovine myoglobin in crops such as pea seeds. Following its 2025 business combination with Bioceres Group, Gentle Technologies, and Nutrecon, the company expanded to include the Mycofood™ fungal precision fermentation platform. The portfolio also includes HB4® soybeans through a supply agreement with Bioceres Crop Solutions. The company is transitioning from development to commercialization, with initial market traction in pet food and expansion planned into human nutrition and dietary supplements.

Product and service4 records
1GLASO1 Safflower Platform (GLA-Rich Safflower Oil)
CategorySpecialty Oil Ingredient (Molecular Farming)
Description

A plant-engineered molecular farming platform producing gamma-linolenic acid (GLA)-rich safflower oil at commercial scale. The platform achieves approximately 45% GLA concentration, with 52 elite genotypes exceeding 60% from 320 candidates. Sold to pet food, human nutrition, dietary supplement, and specialty ingredient manufacturers.

2Molecular Farming Platform (Bovine Myoglobin in Pea Seeds)
CategoryAlternative Protein Ingredient (Molecular Farming)
Description

A plant-based protein expression platform demonstrating stable, multi-generational expression of bovine myoglobin in pea seeds. Expands the company's molecular farming capabilities beyond safflower into alternative crops, targeting alternative protein production for food applications.

3Mycofood™ Fungal Precision Fermentation Platform
CategoryAlternative Protein Ingredient (Precision Fermentation)
Description

A fungal precision fermentation platform for producing specialty food ingredients. Acquired through the June 2025 business combination and integrated as a wholly owned subsidiary, enabling alternative protein and specialty ingredient production via fermentation technology.

4HB4® Soybeans
CategoryAgricultural Input / Licensed Technology
Description

Drought-resistant soybean technology accessed through a supply agreement with Bioceres Crop Solutions, featuring proprietary HB4® gene technology for enhanced crop resilience. Available to support sustainable soybean supply for the company's research, development, and commercialization operations.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Major Global Agribusiness Company
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Strategic research collaboration with a major global agribusiness company for development of next-generation safflower platforms.

stocktitan.net
2U.S. Academic Institution
Strategic tierMinorTypeStrategic or Co-development Partner
Description

28-month sponsored research project with a U.S. academic institution resulting in successful production of bovine myoglobin in pea seeds, demonstrating stable protein expression across multiple generations.

biospace.com
3Australia Germplasm Sources
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Access to germplasm library of 386 safflower varieties sourced from Australia for renewable energy feedstock development and next-generation platform advancement.

greenqueen.com.hk
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Public gene-editing and trait-development company for oilseed crops; directly comparable as a small-cap public plant-biology platform targeting specialty oil and trait economics, and explicitly used as a peer in published Moolec comparisons.

TypeDirect peer
Description

Plant biology company using genomics and trait development to produce specialty plant-based ingredients for food and feed; comparable technology stack and go-to-market motion into CPG and pet food customers.

3Calyxt
TypeDirect peer
Description

Plant-based trait development company focused on specialty oil and ingredient profiles in commodity crops; closely aligned on the model of monetizing differentiated crop output via B2B ingredient sales.

TypeDirect peer
Description

Gene-editing company developing novel crop traits for food and agriculture; comparable in plant-based trait platform targeting fruit, oilseed, and ingredient applications with B2B customer focus.

TypeEmerging player
Description

Israeli molecular farming company producing complex proteins in tobacco plants for food and therapeutic applications; directly comparable technology approach of expressing high-value proteins in plant hosts.

TypeEmerging player
Description

Molecular farming company producing functional proteins (including heme and other animal proteins) in plants; one of the closest technology analogues to Moolec's bovine myoglobin program.

TypeDirect peer
Description

Argentine agtech company with HB4 drought-tolerant soy/wheat traits and an established agricultural inputs business; effectively Moolec's own operating subsidiary post-merger and a direct functional peer in agricultural biotechnology.

TypeBroad incumbent
Description

Precision fermentation leader producing animal-free dairy proteins at commercial scale; comparable as a B2B alternative-protein ingredient supplier targeting food and nutrition customers with a technology-led cost-down roadmap.

TypeEmerging player
Description

Precision fermentation company producing animal proteins (starting with chicken) for the pet food industry; directly comparable target end-market and B2B selling motion into pet food customers.

TypeBroad incumbent
Description

DSM/Evonik joint venture producing omega-3 fatty acids (EPA/DHA) from algae for pet food and aquaculture feed; comparable as a specialty-ingredient supplier selling novel fatty acid profiles into pet food and nutrition end markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Moolec Science

Alternative Protein Ingredientsmoolecscience.com

Moolec Science is a molecular farming company producing GLA-rich safflower oil and animal proteins (e.g., bovine myoglobin) in genetically engineered plants, serving B2B customers in pet food, human nutrition, and dietary supplements. It trades on NASDAQ as MLEC after its June 2025 merger with Bioceres Group.

What Moolec Science does

Moolec Science SA is a molecular farming company that produces animal proteins and specialty oils in genetically engineered crops, trading on NASDAQ under ticker MLEC following a June 2025 business combination with Bioceres Group, Gentle Technologies, and Nutrecon. The company's core technology is a plant-based expression platform that inserts target genes into safflower and pea seeds, producing functional ingredients at agricultural scale. Its lead commercial platform, GLASO1, yields gamma-linolenic acid (GLA)-rich safflower oil at approximately 45% concentration at commercial scale across 1,100 acres in the U.S., with 2025 campaign yields up 57% year-over-year. In April 2026, the company announced the first successful stable expression of bovine myoglobin in pea seeds via a 28-month sponsored research project with a U.S. academic institution, expanding the platform beyond oil crops into structured protein production.

Moolec generates revenue through direct B2B enterprise sales of GLA-rich safflower oil and specialty ingredients, initially targeting pet food manufacturers with planned expansion into human nutrition, dietary supplements, and specialty ingredient markets, and is also pursuing renewable energy feedstock applications through safflower. Following the 2025 merger, the portfolio was broadened to include the Mycofood™ fungal precision fermentation platform (acquired June 2025) and HB4® drought-tolerant soybeans through a supply agreement with Bioceres Crop Solutions. Pricing is not publicly disclosed. The company sells direct to enterprise customers leveraging existing U.S. agricultural and processing infrastructure.

Moolec is controlled by Union Group (founded by Uruguayan businessman Juan Sartori), employs 11-50 staff, and is headquartered in Warwick, UK, with a legal domicile in Uruguay and operations spanning the United States, Argentina, Australia, and Europe. The company has raised approximately $80 million since 2023, including a $50 million committed equity facility from Nomura (April 2023) and a $30 million convertible note financing led by Grupo Insud with Bioceres Crop Solutions (October 2023). It holds USDA-APHIS approval for its GLASO1 ingredient and SENASA feed/food approval in Argentina for safflower GLASO technology. The company regained Nasdaq minimum stockholders' equity compliance in May 2026 after a non-compliance notice in late 2025, and its market capitalization stood at approximately $5.28M as of April 2026 following a ~95.67% stock decline over the prior year.

Moolec Science firmographics

Firmographics
Name
Moolec Science
Legal name
Moolec Science SA
Website
https://moolecscience.com
Company type
Public
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
Moolec Science is a molecular farming company producing GLA-rich safflower oil and animal proteins (e.g., bovine myoglobin) in genetically engineered plants, serving B2B customers in pet food, human nutrition, and dietary supplements. It trades on NASDAQ as MLEC after its June 2025 merger with Bioceres Group.
Ownership category
akta.pro rank

Moolec Science industry classification

Industry
Product category
Alternative Protein Ingredients
NAICS
Fats and Oils Refining and Blending (311225), Dog and Cat Food Manufacturing (311111), Starch and Vegetable Fats and Oils Manufacturing (31122), Other Animal Food Manufacturing (311119)
SIC
Fats & Oils (2070)
akta.pro industry
PRIMARYCRADAFAI
Alternative Protein & Sustainable Pet Food (insect/plant/cell-based)
SECONDARYAFAKAEAE
Specialty & Tropical Oils Processing (Avocado, Sesame, Peanut, Rice Bran, Grapeseed)
Agriculture & Food Production/Food Processing & Manufacturing/Edible Oils, Fats & Margarine Manufacturing
SECONDARYAFAKAGAG
Mycoprotein-Based Foods Manufacturing
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYEUAAAIAI
Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYAFADAKAF
Phytogenics & Botanicals (Essential Oils, Plant Extracts)
Agriculture & Food Production/Animal Feed Manufacturing/Medicated & Functional Feed (Coccidiostats, Probiotics, Performance Additives)

Keywords

  • Molecular farming proteins
  • Alternative protein ingredients
  • Specialty oil ingredients
  • Plant-based proteins
  • Precision fermentation ingredients

Where Moolec Science is headquartered

Location

Headquarters

HQ city
Luxembourg
HQ country
Luxembourg
HQ region
Europe

Offices1 record

Markets served

Moolec Science business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. GLA-Rich Safflower Oil Sales: Revenue from commercial-scale production and sale of GLA-enriched safflower oil to pet food, human nutrition, and dietary supplement markets.
  2. Specialty Ingredients: Revenue from high-concentration GLA softgel applications and specialty ingredient sales to nutrition and supplements market.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Moolec Science product offering

Product offering

Core offering

Moolec Science develops and produces animal proteins and specialty oils using molecular farming technology—genetically engineering crops such as safflower and peas to express high-value proteins (e.g., bovine myoglobin) or fatty acids (e.g., gamma-linolenic acid/GLA). Its commercial flagship is the GLASO1 safflower platform producing GLA-rich safflower oil at commercial scale for pet food, human nutrition, and dietary supplement applications. The company also operates the Mycofood™ fungal precision fermentation platform acquired through its 2025 merger.

Product overview

Moolec Science is a molecular farming company that develops animal proteins in plants across the US, Europe, and South America. The company operates primarily through its GLASO1 Safflower Platform, which produces GLA-rich safflower oil at commercial scale, and its Molecular Farming Platform, which expresses proteins like bovine myoglobin in crops such as pea seeds. Following its 2025 business combination with Bioceres Group, Gentle Technologies, and Nutrecon, the company expanded to include the Mycofood™ fungal precision fermentation platform. The portfolio also includes HB4® soybeans through a supply agreement with Bioceres Crop Solutions. The company is transitioning from development to commercialization, with initial market traction in pet food and expansion planned into human nutrition and dietary supplements.

Differentiator

Problem solved

Functional benefit

Brands

  • GLASO1: GLA-enriched safflower platform producing gamma-linolenic acid oil at commercial scale
  • Mycofood™

Products and services

  • GLASO1 Safflower Platform (GLA-Rich Safflower Oil) A plant-engineered molecular farming platform producing gamma-linolenic acid (GLA)-rich safflower oil at commercial scale. The platform achieves approximately 45% GLA concentration, with 52 elite genotypes exceeding 60% from 320 candidates. Sold to pet food, human nutrition, dietary supplement, and specialty ingredient manufacturers.
  • Molecular Farming Platform (Bovine Myoglobin in Pea Seeds) A plant-based protein expression platform demonstrating stable, multi-generational expression of bovine myoglobin in pea seeds. Expands the company's molecular farming capabilities beyond safflower into alternative crops, targeting alternative protein production for food applications.
  • Mycofood™ Fungal Precision Fermentation Platform A fungal precision fermentation platform for producing specialty food ingredients. Acquired through the June 2025 business combination and integrated as a wholly owned subsidiary, enabling alternative protein and specialty ingredient production via fermentation technology.
  • HB4® Soybeans Drought-resistant soybean technology accessed through a supply agreement with Bioceres Crop Solutions, featuring proprietary HB4® gene technology for enhanced crop resilience. Available to support sustainable soybean supply for the company's research, development, and commercialization operations.

Quantifiable outcome

  • 45% GLA concentration at commercial scale from 1,100 acres, 57% yield increase year-over-year
  • +2 more outcomes

Companies that use Moolec Science

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Moolec Science technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Moolec Science partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor.

  • Major Global Agribusiness CompanyminorStrategic or Co-development PartnerStrategic research collaboration with a major global agribusiness company for development of next-generation safflower platforms.
  • U.S. Academic InstitutionminorStrategic or Co-development Partner28-month sponsored research project with a U.S. academic institution resulting in successful production of bovine myoglobin in pea seeds, demonstrating stable protein expression across multiple generations.
  • Australia Germplasm SourcesminorStrategic or Co-development PartnerAccess to germplasm library of 386 safflower varieties sourced from Australia for renewable energy feedstock development and next-generation platform advancement.

Scale indicators8 records

Recent moves7 records

Expansion highlights6 records

Moolec Science competitors and assessment

Company assessment

Direct peers

  • Cibus: Public gene-editing and trait-development company for oilseed crops; directly comparable as a small-cap public plant-biology platform targeting specialty oil and trait economics, and explicitly used as a peer in published Moolec comparisons.
  • Benson Hill: Plant biology company using genomics and trait development to produce specialty plant-based ingredients for food and feed; comparable technology stack and go-to-market motion into CPG and pet food customers.
  • Calyxt: Plant-based trait development company focused on specialty oil and ingredient profiles in commodity crops; closely aligned on the model of monetizing differentiated crop output via B2B ingredient sales.
  • Pairwise: Gene-editing company developing novel crop traits for food and agriculture; comparable in plant-based trait platform targeting fruit, oilseed, and ingredient applications with B2B customer focus.
  • Bioceres Crop Solutions: Argentine agtech company with HB4 drought-tolerant soy/wheat traits and an established agricultural inputs business; effectively Moolec's own operating subsidiary post-merger and a direct functional peer in agricultural biotechnology.

Emerging players

  • BioBetter: Israeli molecular farming company producing complex proteins in tobacco plants for food and therapeutic applications; directly comparable technology approach of expressing high-value proteins in plant hosts.
  • IngredientWerks: Molecular farming company producing functional proteins (including heme and other animal proteins) in plants; one of the closest technology analogues to Moolec's bovine myoglobin program.
  • Bond Pet Foods: Precision fermentation company producing animal proteins (starting with chicken) for the pet food industry; directly comparable target end-market and B2B selling motion into pet food customers.

Broad incumbents

  • Perfect Day: Precision fermentation leader producing animal-free dairy proteins at commercial scale; comparable as a B2B alternative-protein ingredient supplier targeting food and nutrition customers with a technology-led cost-down roadmap.
  • Veramaris: DSM/Evonik joint venture producing omega-3 fatty acids (EPA/DHA) from algae for pet food and aquaculture feed; comparable as a specialty-ingredient supplier selling novel fatty acid profiles into pet food and nutrition end markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Moolec Science social profiles

Digital presence

Moolec Science compliance and trust

Trust signal

Compliance2 records

Moolec Science financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Moolec Science leadership team

Management profile

Number of profiles

Profiles6 records

Moolec Science subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Moolec Science funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Moolec Science M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Moolec Science

What does Moolec Science do?

Moolec Science develops and produces animal proteins and specialty oils using molecular farming technology—genetically engineering crops such as safflower and peas to express high-value proteins (e.g., bovine myoglobin) or fatty acids (e.g., gamma-linolenic acid/GLA). Its commercial flagship is the GLASO1 safflower platform producing GLA-rich safflower oil at commercial scale for pet food, human nutrition, and dietary supplement applications. The company also operates the Mycofood™ fungal precision fermentation platform acquired through its 2025 merger.

Is Moolec Science a public or private company?

Moolec Science is a public company. It is classified as public and is currently operating.

When was Moolec Science founded?

Moolec Science was founded in 2025. It employs 1 to 10 people.

Where is Moolec Science based?

Moolec Science is headquartered in Luxembourg, Luxembourg, in the Europe region.

How does Moolec Science make money?

Two revenue lines are on record. GLA-Rich Safflower Oil Sales are the primary driver. The others are specialty Ingredients.

Who are Moolec Science's main competitors?

Direct peers on record are Cibus, Benson Hill, Calyxt, Pairwise and Bioceres Crop Solutions. Emerging players are BioBetter, IngredientWerks and Bond Pet Foods. Broad incumbents are Perfect Day and Veramaris.

Does Moolec Science have an API?

No public API is recorded for Moolec Science.

What industry is Moolec Science in?

Moolec Science's product category is Alternative Protein Ingredients. Its primary akta.pro industry code is CRADAFAI, Alternative Protein & Sustainable Pet Food (insect/plant/cell-based), with a secondary code of AFAKAEAE, Specialty & Tropical Oils Processing (Avocado, Sesame, Peanut, Rice Bran, Grapeseed). Its NAICS code is 311225 and its SIC code is 2070.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Investing.comMoolec Science shares to be delisted from Nasdaq TuesdayMoolec Science's Nasdaq shares will be delisted Tuesday after shareholder approval of voluntary liquidation. The Extraordinary General Meeting on October 20 approved the winding-up with 98.4% of votes cast in favor. Trading will be suspended at market open, and Nasdaq will file a Form 25-NSE with the SEC.Stock TitanMoolec Science receives Nasdaq delisting determinationMoolec Science SA received a Nasdaq delisting determination on October 27, 2026, following shareholder approval of voluntary liquidation. The resolution passed with 98.4% of votes cast in favor. Trading will be suspended on November 3, 2026, and Nasdaq will file a Form 25-NSE for delisting.American Banking and Market NewsMoolec Science SA (NASDAQ:MLEC) Stock Short Interest Rises 97.5%Short interest in Moolec Science SA rose 97.5% to 5,571 shares as of October 15th, up from 2,821 on September 30th. The stock opened at $1.40 with a market cap of $1.02 million, and 1.0% of shares are sold short.El CronistaNuevas esquirlas de la caída de Bioceres: su exdueña quedó sin financiamiento y va por la “solución” en paraíso offshoreMoolec Science approved voluntary liquidation of Bioceres Crop Solutions after losing control and access to financing, with 98.4% of shareholder votes. The resolution was adopted at an extraordinary assembly on October 20, appointing Cassandra Ronaldson and Amiel Gottlieb as liquidators under Cayman law. The company had warned of doubts about its ability to continue operating.Markets DailyMoolec Science SA (NASDAQ:MLECW) Sees Significant Drop in Short InterestMoolec Science SA saw short interest fall 97.7% to 196 shares as of October 15th, down from 8,479 on September 30th. The stock traded flat at $0.01 with volume of 2,978 shares, well below its average of 396,589. The company develops molecular farming technologies using genetically engineered plants.LA NACIONQuería ser el “unicornio del agro”, llegó a valer más de US$1000 millones y ahora aprobaron su liquidación con el 98,4% de los votosMoolec Science SA shareholders approved its voluntary liquidation at a virtual meeting, with about 98.4% of votes cast. The Cayman Islands company, which once valued over $1 billion, will be dissolved under Cayman law, with Cassandra Ronaldson and Amiel Gottlieb named joint liquidators.El CronistaLa sociedad que controla Bioceres pide su propia liquidación y peligra la empresaMoolec Science, the controlling entity of Bioceres, proposed voluntary liquidation to shareholders on October 20. The company lost funding sources and reported a $54.4 million net loss for the year, with negative working capital. The proposal awaits shareholder approval.LA NACIONLlegó a valer más de US$1000 millones: una empresa del agro convocó a sus accionistas a votar su liquidaciónMolec Science SA called a shareholder meeting to vote on voluntary liquidation under Cayman law, recommending approval. The company, once a $1000M unicorn, is now controlled by Bioceres SA, which filed for bankruptcy. The vote is set for October 20, with liquidators to be named.Markets DailyMoolec Science SA (NASDAQ:MLEC) Shares Shorted: Short Interest Down 68.4% in SeptemberMoolec Science's short interest fell 68.4% to 2,821 shares as of September 30, down from 8,919 on September 15. The stock traded down $0.40 to $1.80 on Monday, with a market cap of $1.31 million. The company develops alternative animal proteins via genetically engineered plants.LA NACIONCaso Bioceres: desestimaron una denuncia por una supuesta estafa en una millonaria transferencia de accionesThe Public Prosecutor's Office in Santa Fe dismissed a fraud complaint filed by Bioceres Crop Solutions CEO Federico Trucco regarding the transfer of 5.3 million shares valued at approximately US$12 million, citing insufficient evidence. The decision concludes an investigation into allegations involving former executive Gloria Montarón Estrada and a transaction linked to Moolec Science. Bioceres sources indicated that further legal actions may be pursued in other jurisdictions, including the United States.